Regeneron Pharmaceuticals (REGN) Cash & Equivalents Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 67.78% |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.13% |
| Dec 31, 2025 | 25.32% |
| Sep 30, 2025 | 24.58% |
| Jun 30, 2025 | 3.91% |
| Mar 31, 2025 | 18.76% |
| Dec 31, 2024 | -8.86% |
| Sep 30, 2024 | -6.53% |
| Jun 30, 2024 | -0.85% |
| Mar 31, 2024 | -33.56% |
| Dec 31, 2023 | -12.10% |
| Sep 30, 2023 | -38.35% |
| Jun 30, 2023 | -42.94% |
| Mar 31, 2023 | 17.05% |
| Dec 31, 2022 | 7.63% |
| Sep 30, 2022 | 1.72% |
| Jun 30, 2022 | 63.84% |
| Mar 31, 2022 | 132.68% |
| Dec 31, 2021 | 31.54% |
| Sep 30, 2021 | 118.21% |
| Jun 30, 2021 | 4.02% |
| Mar 31, 2021 | -34.88% |
| Dec 31, 2020 | 35.60% |
| Sep 30, 2020 | 13.59% |
| Jun 30, 2020 | 90.55% |
| Mar 31, 2020 | 29.25% |
| Dec 31, 2019 | 10.23% |
| Sep 30, 2019 | 27.30% |
| Jun 30, 2019 | 13.90% |
| Mar 31, 2019 | 67.58% |
| Dec 31, 2018 | 80.60% |
| Sep 30, 2018 | 37.34% |
| Jun 30, 2018 | 23.32% |
| Mar 31, 2018 | 25.59% |
| Dec 31, 2017 | 51.85% |
| Sep 30, 2017 | -13.94% |
| Jun 30, 2017 | 15.13% |
| Mar 31, 2017 | 34.35% |
| Dec 31, 2016 | -33.85% |
| Sep 30, 2016 | 40.60% |
| Jun 30, 2016 | 65.54% |
| Mar 31, 2016 | 18.96% |
| Dec 31, 2015 | 24.72% |
| Sep 30, 2015 | 1.24% |
| Jun 30, 2015 | -34.92% |
| Mar 31, 2015 | 9.97% |
| Dec 31, 2014 | 21.12% |
| Sep 30, 2014 | 145.64% |
| Jun 30, 2014 | 57.24% |
| Mar 31, 2014 | 156.07% |
| Dec 31, 2013 | 132.59% |
| Sep 30, 2013 | 121.19% |
| Jun 30, 2013 | 121.98% |
| Mar 31, 2013 | -54.29% |
| Dec 31, 2012 | -52.38% |
| Sep 30, 2012 | -42.34% |
| Jun 30, 2012 | -32.39% |
| Mar 31, 2012 | 191.47% |
| Dec 31, 2011 | 329.60% |
| Sep 30, 2011 | -36.55% |
| Jun 30, 2011 | 127.06% |
| Mar 31, 2011 | 15.40% |
| Dec 31, 2010 | -45.64% |
| Sep 30, 2010 | 29.95% |
| Jun 30, 2010 | -58.74% |